Back to search
FDAFDA · Food and drugs·Recall number D-0640-2022

Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg, 30 individual packets per carton, Rx Only, Dr. Reddy's, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC: 43598-477-11 (packet), 43598-477-30 (carton).

Published March 2, 2022 · Recall initiated: February 17, 2022

Summary

FDA records drug Class III recall D-0640-2022, published March 2, 2022 and initiated February 17, 2022. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 340 packets; Lot: T2100891, Exp. 02/28/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Out-of-specification results observed in Assay in sapropterin dihydrochloride powder 100mg.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide in the USA.
Lot
T2100891, Exp. 02/28/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg, 30 individual packets per carton, Rx Only, Dr. Reddy's, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC: 43598-477-11 (packet), 43598-477-30 (carton). recalled?

Yes. FDA published recall D-0640-2022 on March 2, 2022. Reported hazard: Subpotent Drug: Out-of-specification results observed in Assay in sapropterin dihydrochloride powder 100mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter